Citius Pharmaceuticals Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Extended Market Index Fund

27,063

0.17%

07/31/2018

Vanguard Total Stock Market Index Fund

22,052

0.14%

07/31/2018

DFA US Core Equity 2 Portfolio

13,938

0.09%

3,417

04/30/2018

View Profile

Address	11 Commerce Drive Cranford New Jersey 07016 United States
Employees	-
Website	http://www.citiuspharma.com
Updated	07/08/2019
Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. Its products include Mino-Lok and hydrocortisone-lidocaine. The company was founded on September 09, 2010 and is headquartered in Cranford, NJ.